HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saadi, H. F Articles by Nagelkerke, N. Search for Related Content PubMed PubMed Citation Articles by Saadi, H. F Articles by Nagelkerke, N. Agricola Articles by Saadi, H. F Articles by Nagelkerke, N.

Efficacy of daily and monthly high-dose calciferol in vitamin D–deficient nulliparous and lactating women^1,2,3

¹ From the Departments of Internal Medicine (HFS and SB) and Community Medicine (NN), Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates (UAE); the Department of Internal Medicine, Tawam Hospital, Al Ain, UAE (BOA); the Department of Preventive Medicine, General Authority for Health Services for Abu Dhabi, Al Ain, UAE (RZ); and the International Health Program Center for Epidemiology and Biostatistics, Cincinnati Children's Medical Center, Cincinnati, OH (AD)

Background: We previously found a high prevalence of vitamin D deficiency and low medication regimen compliance in Arab and East Indian women residing in the United Arab Emirates (UAE). The appropriate dosing regimen for improving vitamin D status in this population is not known.

Objective: We aimed to determine the efficacy of daily and monthly supplementation with vitamin D₂, the only high-dose calciferol available in the UAE, in lactating and nulliparous women.

Design: Healthy lactating (n = 90) and nulliparous (n = 88) women were randomly assigned to consume 2000 IU vitamin D₂/d or 60 000 IU vitamin D₂/mo for 3 mo. Serum 25-hydroxyvitamin D [25(OH)D] concentrations were measured by radioimmunoassay at baseline and every month.

Results: Most women had vitamin D deficiency [ie, 25(OH)D < 50 nmol/L] at study entry. Mean ± SD 25(OH)D concentrations at 3 mo were significantly higher than baseline in both lactating (39.8 ± 12.4 and 25.2 ± 10.7 nmol/L, respectively) and nulliparous (40.4 ± 23.4 and 19.3 ± 12.2 nmol/L, respectively) women (P < 0.001 for both). In total, vitamin D supplementation was effective in achieving serum 25(OH)D concentrations of 50 nmol/L in 21 (30%) of 71 women at endpoint.

Conclusions: Oral vitamin D₂ supplementation with 2000 IU/d or 60 000 IU/mo for 3 mo was safe, and it increased serum 25(OH)D concentrations significantly; however, only a small proportion of the women studied achieved concentrations of 50 nmol/L. This suggests that, when sunlight exposure is limited, doses of vitamin D₂ higher than those currently studied may be needed. Monthly dosing appears to be a safe and effective alternative to daily dosing.

Key Words: Vitamin D deficiency • 25-hydroxyvitamin D • 25(OH)D • lactating women • nulliparous women • Arab women

This article has been cited by other articles:

				A. Dawodu and C. L Wagner Mother-child vitamin D deficiency: an international perspective Arch. Dis. Child., September 1, 2007; 92(9): 737 - 740. [Full Text] [PDF]